Refractory CLL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (NCT06916767) | Paolo Caimi, MD | 2025-07-15 |
Track Refractory CLL automatically
Every clearance here is in the API, with alerts when new ones post.